Agonists of epoxyeicosatrienoic acids reduce infarct size and ameliorate cardiac dysfunction via activation of HO-1 and Wnt1 canonical pathway
Keywords: β-catenin, beta cadherin associated protein; CYP, cytochrome P450; Dkk-1, Dickkopf 1; eNOS, endothelial nitric oxide synthetase; EETs, epoxyeicosatrienoic acids; ET, ejection time; FAC, fractional area change; gp91(phox), glycosylated subunit of nicotinam